The transmembrane (TM) envelope protein of lentiviruses, including equine infectious anemia virus (EIAV), is significantly larger than that of other retroviruses and may extend in the C-terminal direction 100 to 200 amino acids beyond the TM domain. This size difference suggests a lentivirus-specific function for the long C-terminal extension. We have investigated the synthesis and processing of the EIAV TM protein by immune precipitation and immunoblotting experiments, by using several envelope-specific peptide antisera. We show that the TM protein in EIAV particles is cleaved by proteolysis to an N-terminal glycosylated 32-to 35-kilodalton (kDa) segment and a C-terminal nonglycosylated 20-kDa segment. The 20-kDa fragment was isolated from virus fractionated by high-pressure liquid chromatography, and its N-terminal amino acid sequence was determined for 13 residues. Together with the known nucleotide sequence, this fixes the cleavage site at a His-Leu bond located 240 amino acids from the N terminus of the TM protein. Since the 32-to 35-kDa fragment and the 20-kDa fragment are not detectable in infected cells, we assume that cleavage occurs in the virus particle and that the viral protease may be responsible. We have also found that some cells producing a tissue-culture-adapted strain of EIAV synthesize a truncated envelope precursor polyprotein. The point of truncation differs slightly in the two cases we have observed but lies just downstream from the membranespanning domain, close to the cleavage point described above. In one case, virus producing the truncated envelope protein appeared to be much more infectious than virus producing the full-size protein, suggesting that host cell factors can select for virus on the basis of the C-terminal domain of the TM protein.
Equine infectious anemia virus (EIAV) is a lentivirus, related in genome organization (23, 36, 38) , sequence (6, 23, 36, 38) , and morphology (12) to the human immunodeficiency virus (HIV), the cause of acquired immunodeficiency syndrome. Depending on the host and the virus strain, an EIAV-infected horse may (i) suffer a brief acute illness and die, (ii) undergo multiple cycles of illness and recovery, or (iii) remain clinically normal. Acute episodes involve fever, viremia, weight loss, and leucopenia; and animals who have multiple episodes become severely anemic and may show central nervous system impairment. As with HIV, EIAV persists even in clinically normal individuals, and blood cells have been found to be infectious after disease-free intervals of many years (7, 22) . The principal target cell is a leukocyte, probably the macrophage (22, 30, 31, 35) .
Retrovirus transmembrane (TM) envelope proteins share a number of common features (for a review, see reference 11 and E. Hunter and R. Swanstrom, Curr. Top. Microbiol. Immunol., in press). They all have two highly hydrophobic regions separated by a 110-to 160-amino-acid stretch that contains at least two cysteine residues. One of these regions is at or near the N terminus and is thought to play a role in fusing the viral envelope with that of the host cell. The second hydrophobic stretch is the presumptive membranespanning region. Most retrovirus TM proteins, including those of type B, C, and D viruses, as well as those of the HTLV-I group, end within 50 amino acids downstream of the TM domain. Most lentivirus TM proteins, on the other hand, are considerably longer and may extend for more than 100 residues beyond the TM domain. In EIAV, this C-methionine and cysteine.
[35S]methionine and [35S]cysteine (600 to 1,000 Ci/mmol; Amersham Corp.) were added to a final level for each of 50 to 100 ,uCi/ml. For analysis of cellular lysates, the incubation time was 2 h; for analysis of viral particles, the incubation time was 5 h. Virus was isolated as described above for the macrophage cultures.
Immune precipitation. Viral pellets or cells were lysed in TNT buffer (20 mM Tris [pH 7 .5], 200 mM NaCl, 1% Triton X-100) containing 1 mM phenylmethylsulfonyl fluoride and 200 Kallikrein units of aprotinin per ml, and lysates were centrifuged for 10 min at 10,000 x g in an Eppendorf microfuge. Viral supernatants were incubated directly with antisera and protein A-Sepharose (Pharmacia, Inc.). Cellular supernatants were first boiled in 1% sodium dodecyl sulfate (SDS)-1% 3-mercaptoethanol (,ME) before dilution with TNT and incubation with antisera and protein A-Sepharose. Immune precipitates were collected, washed in TNT, boiled in gel loading dye, and applied to SDS-polyacrylamide gels.
For endoglycosidase F (endo F) digestion, a 30 RI sample of a solution containing 0.05 M potassium phosphate (pH 6.8),
20 mM EDTA, 1% PME, 1% Triton X-100, and 0.2% SDS was added to the washed immune precipitates; the suspensions were boiled for 5 min; and 0.2 U of endo F (grade II; Boehringer Mannheim Biochemicals) was then added to each sample. They were incubated at 37°C for 4 h, whereupon they were boiled in gel loading dye and applied to a gel. Immunoblotting. The virus-containing pellet from an 8-day culture of EIAV-infected horse macrophages was suspended in 100 ,ul of gel loading dye and boiled. The high-speed pellet from a mock-infected culture was treated identically. min in complete medium containing 20 ,ug of DEAE-dextran per ml. This medium was then removed, and 0.5 ml of virus-containing medium was applied and incubated for 30 min. Complete medium containing 5 p.g of Polybrene per ml was then added. Cultures were propagated and analyzed for virus production after several passes. The virus-containing medium was taken from a confluent virus-producing culture and was clarified and sterile filtered before use. For electroporation, 50 ,ug of DNA prepared as described previously (35) was added to 106 Cf2Th cells in 1 ml of ice-cold phosphate-buffered saline. The mixture was pulsed, allowed to rest 10 min at 0°C, and diluted with 1 ml of complete medium. After 10 min at room temperature, the mixture was transferred to a T75 culture flask and propagated as usual. Amplification of a portion of the env gene. Deoxyoligonucleotides used in the amplification were 5'-GGATTCCTG GATTGGGAGC-3' (bases 509 to 527 of the TM-proteincoding sequence) and 5'-CAATTGTCAGAATACAAGC AC-3' (complementary to bases 168 to 188 of the long terminal repeat). A 0.5-,ug portion of cellular DNA was mixed with 20 pmol of each oligonucleotide in 100 ,ul of buffer containing 10 mM Tris hydrochloride (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.01% gelatin, 200 puM each all four deoxynucleoside triphosphates, and 2.5 U of Thermus aquaticus polymerase (Cetus-Perkin Elmer). The resulting mixture was subjected to 35 cycles of denaturation (95°C for 1 min), annealing (50°C for 2 min), and extension (72°C for 10 min), by using the Ericomp thermal cycler. Amplification of a 0.96-kilobase (kb) fragment was confirmed by electrophoresis of a sample of the product. The remainder of the reaction product was extracted with an equal volume of chloroform, and DNA was precipitated by the addition of 2 volumes of ethanol. The suspended precipitate was digested with the restriction endonucleases ApaI and SpeI, yielding a 0.47-kb fragment, which was purified by electrophoresis in a 1.2% gel of low-melting-point agarose. The ApaI and SpeI sites follow bases 603 and 1071, respectively, of the TMprotein-coding sequence. This fragment was cloned into BlueScript-KS (Stratagene), which had been digested with ApaI and SpeI. Individual white colonies were selected and expanded, and minipreparations of DNA were sequenced by the dideoxy-chain termination method (37) by using the Sequenase system and protocol (U.S. Biochemical Corp.).
The sequencing primer was 5'-GGCCCTCTGGAAAGTG ACC-3' (bases 600 to 618 for the TM-protein-coding sequence).
Peptides and antisera. Three TM protein peptides were synthesized, coupled, and administered to rabbits as described previously (34) . The sequence of peptide tm-1 is Lys-Glu-Arg-Gln-Gln-Val-Glu-Glu-Thr-Phe-Asn-Leu-IleGly-Cys (residues 77 to 91 of the TM protein [2, 36] ), and it was coupled to keyhole limpet hemocyanin via its C-terminal cysteine. Peptide tm-2 is Cys-Gly-Ser-Gly-Asp-Lys-TyrTyr-Lys-Gln-Lys-Tyr-Ser-Arg (residues 247 to 259 of the TM protein), and peptide tm-3 is Cys-Leu-Asn-Pro-GlyThr-Ser-His-Val-Ser-Met-Pro-Gln-Tyr-Val (residues 402 to 415). The N-terminal cysteines do not occur in the EIAV sequence and were added to facilitate coupling.
Surface glycoprotein peptides were purchased in crude form from Peninsula Laboratories. Peptide sgp-1 is CysAla-Glu-Ser-Lys-Glu-Ala-Arg-Asp-Gln-Glu-Met-Asn-LeuLys-Glu (residues 41 to 55 of the mature protein [1, 29] ), and peptide sgp-2 is Cys-Leu-Pro-Ile-Ser-Ser-Glu-Ala-Asn-ThrGly-Leu-Ile-Arg-His-Lys-Arg (residues 424 to 439). The N-terminal cysteines of each were added to facilitate coupling.
RESULTS
To investigate the EIAV env gene products, antisera to five env peptides were raised (Fig. 1) . Two of the peptides are part of the surface glycoprotein (one near the N-terminus and the other at the extreme C-terminus), and three are part of the TM protein (one upstream of the putative membranespanning region and two in the long C-terminal extension).
Rabbit antisera to these peptides were used in immune precipitation and immunoblotting experiments with viral and cellular lysates.
Identification of env gene products by immune precipitation. Immune precipitation of radiolabeled viral proteins with the surface glycoprotein antisera (anti-sgp-1 and anti-sgp-2) revealed in SDS-polyacrylamide gel electrophoresis (PAGE) analysis a single broad band corresponding to gp9O, as described by Parekh et al. (33) the nucleotide sequence (439 amino acids) (23, 36) . Since the 48-kDa protein was produced by virus both from canine and equine cells, the difference in the mature forms must result from their pattern and/or extent of glycosylation and sialylation. Thus, antisera to peptides near the N-and C-termini of the predicted surface glycoprotein revealed a single protein species of the expected molecular weight.
In contrast, antisera to peptides from the predicted TM protein recognized more than one protein in lysates of radiolabeled particles produced by cultured canine cells. . :
_.
-43 3) , which is clearly too small to represent the entire coding region. Antiserum to the C-terminal peptide tm-3, on the other hand, did not precipitate the 32-kDa species but instead recognized an unglycosylated molecule of about 20 kDa (lanes 6 and 7). The simplest interpretation of these results is that the 415-residue TM protein undergoes cleavage to an upstream gp32 portion and a downstream p20 segment. The 46-kDa protein in lane 6 probably represents the uncleaved fulllength molecule, which, upon endo F treatment, was reduced to 40 kDa (lane 7). This interpretation is tentative, however, since the putative full-length protein was not recognized by anti-tm-1 (lane 2).
Essentially the same results were obtained with virus from equine kidney cells. As with the surface glycoproteins (gp90 and gplOO), the upstream portion of the TM protein was slightly larger in the equine cells (gp35) than in the canine cells (gp32) (Fig. 4A , lanes 2 and 4), but endo F treatment resulted in a 23-kDa protein in both cases (Fig. 4A , lanes 3 and 5). In addition, virus from the canine cells contained (after digestion) a 22-kDa protein (C in Fig. 4A , lane 3), the origin of which is documented below. As in the canine cells, anti-tm-3 precipitated an unglycosylated p20 as well as the putative full-length uncleaved TM protein (Fig. 4B, lanes 4 and 5). None of these proteins was detectable in uninfected cells ( Fig. 4A and B, lanes 1) .
To confirm a viral origin for the observed proteins, we used four additional antisera. Each of three antisera from EIAV-infected horses precipitated not only the surface glycoprotein but also gp32 and gp35 (Fig. 4A, lanes 7, 9, 11 , and 12). Like anti-tm-3, anti-tm-2 precipitated p20 from canine and equine cells (Fig. 4B, lanes 7 and 8) but not from uninfected cells (Fig. 4B, lane 6) . Anti-tm-2 also recognized the putative uncleaved gp48; its size, like those of gp90 and gplOO and gp32 and gp35, appears to differ slightly between the canine and equine cell viruses (Fig. 4B, lanes 2, 4, 7 Isolation and N-terminal sequencing of p20. The isolation and purification by reversed-phase high-pressure liquid chromatography of EIAV gag proteins have been described previously (18) . Briefly, disrupted virus was fractionated in an acetonitrile gradient and the fractions were assayed by SDS-PAGE. Major peaks of optical density were analyzed for the N-terminal sequence, and the viral origin of the protein in question was confirmed by reference to the nucleotide sequence (38) . During the course of this work, a protein of about 20 kDa was found and shown to have the N-terminal sequence Leu-Ala-Gly-Val-Thr-Gly-Gf&-SerGly-Asp-Lys-Tyr-Tyr. Subsequently, the nucleotide sequence of the EIAV env gene was reported (36) . It showed that this protein begins 175 amino acids upstream of the C terminus of the predicted env precursor protein, making it a likely candidate for the p20 described above. This result is completely consistent with the immune precipitation experiments, which predict a cleavage site immediately upstream of peptide tm-2. In the sequence given above, the third glycine (underlined) is the N terminus of peptide tm-2, so that cleavage occurred only six residues upstream. We conclude that p20 predicted from the use of peptide antisera in precipitation experiments can be identified in bulk preparations of purified virus.
The actual cleavage site predicted from the amino acid sequence above together with the nucleotide sequence is Ile-His/Leu-Ala. While not typical of sequences cleaved by viral proteases, it is not so dissimilar that cleavage by a cellular enzyme must be invoked. In particular, there is precedent among the viral proteases for cleavage next to a His residue, and branched amino acids such as Ile are often observed at P2 and P2' sites (21) .
Cleavage does not occur intracellularly. Examination of cellular rather than viral lysates should reveal whether cleavage to gp32 or gp35 and p20 occurs intracellularly or after budding. In virus-producing equine kidney cells grown for 2 h in 3"S-labeled precursors, we expect to detect the newly synthesized envelope precursor (854 amino acids). Since cleavage of this precursor to yield the surface glycoprotein and the full-length TM protein is expected to be accomplished by a cellular enzyme (by analogy to other retroviruses), these two proteins should be detected as well. The question is will gp35 and p20 be seen? Figure 5 shows that they are not. Four env antisera precipitated the highmolecular-weight glycosylated translational product of the env gene, gPrefV, which, upon treatment with endo F, was reduced in size to about 95 kDa, as expected. Anti-sgp-2 also precipitated the mature surface glycoprotein gplO0, which (as in Fig. 2 , lane 5) was reduced to 48 kDa upon endo F treatment (Fig. 5, lanes 1 and 2) . Anti-tm-2 and anti-tm-3 precipitated the 48-kDa endo F-sensitive protein we presume a-sgp-2+ am-1 . p20 from tissue-culture-adapted virus could be detected by immunoblotting, by using either anti-tm-2 or anti-tm-3 (Fig.  6A, lanes 3 to 6) , but gp32 and gp35 were not detectable with anti-tm-1 (lanes 1 and 2) or with immune horse sera, except after very long exposure. Viral lysates from the cultured horse macrophages were therefore examined only with antitm-2 and anti-tm-3. Both of these antisera recognized a protein of 20 kDa that was not present in the uninfected control (Fig. 6B) (Fig. 7A, lanes 6 to 9) . Since the smaller precursor (Pr2) was precipitated by both surface glycoprotein antisera and by anti-tm-1 and anti-tm-2 (lanes 1 to 4) but not by anti-tm-3 (lane 5), it appears to be truncated at its C terminus relative to the full-size precursor Pr1. Since it lacks about 18 kDa relative to Pr1 but was still recognized by anti-tm-2, the truncation must have occurred immediately downstream of peptide tm-2. Both forms of precursor were synthesized by these cells. Virus-producing canine thymus cells also synthesized two env precursors (Fig. 7B) (Fig. 8B, lanes 6, 8, and 12) . All of the env precursor in culture IV was the same size as Pr2 of the parental culture (lanes 7 to 10).
Two conclusions can be drawn from these results. First, since the electroporated cultures I and IV contained only Pr2, virus expressing only Pr2 must be infectious for canine cells. Second, since passage of virus from the parental culture to culture II that Pr2 resulted from a mutant genome(s) containing either a 3' deletion or a premature translation termination signal in the env gene. Since Pr2 was recognized by anti-tm-1 but not by anti-tm-2 or anti-tm-3 in the canine cells, such a mutation presumably occurred upstream of the tm-2 peptide. To test this theory, we amplified, subcloned, and sequenced a portion of the env gene from the parental Cf2Th(EIAV) culture and from culture II. The sequences of 12 env subclones from the parental culture revealed that four of them had in-frame termination codons slightly upstream of peptide tm-2 (Fig. 9) . Singlebase changes (relative to the prototype sequence [36] ) at 11 other positions were also observed among the subclones, but these did not result in termination signals. Thus, an open reading frame was maintained in eight of the subclones.
These results are consistent with the synthesis of both Pr, and Pr2 by cells of the parental culture. In contrast, 8 of 10 subclones from culture II had in-frame terminators upstream of peptide tm-2. One additional subclone terminated downstream of peptide tm-2 as a result of a single-base deletion. Only 1 of the 10 maintained an open frame in this region. These results account for the preponderance of Pr2 synthesized by culture II. Thus, the truncated env precursor results from premature termination codons in the env gene. In 12 of the 13 cases we observed, these terminators were located 7, 9, or 12 codons upstream of the gp32-p20 cleavage site.
A truncated TM protein is detectable in virus. Cleavage products expected from the full-size and truncated precursors are shown in Fig. 10 . Cleavage of Pr1 yields the surface glycoprotein, the mature TM protein (gp32-35), and p20, as documented in the preceding sections of this report. Cleavage of equine Pr2, which extends through peptide tm-2, should also yield the mature TM protein (A in Fig. 10 9 . Portion of the env gene sequence, along with its translation products, for the prototype EIAV strain (36) . The sequence begins 20 residues downstream of the putative membrane-spanning region of the TM protein and continues through the peptide tm-2 region (residues 217 to 259 of the TM protein). Cellular DNAs from the parental Cf2Th(EIAV) culture and from culture II were amplified by using the polymerase chain reaction, and amplified material was subcloned and sequenced. The number of subclones that were sequenced is given in parentheses. Sequences were identical to the prototype except where indicated. Subscripts denote the number of clones with each change. Boxes indicate that stop codons were created by the sequence changes. The dash denotes a deletion. The arrow indicates the cleavage site between gp32 and p20.
as a short peptide (B in Fig. 10 ) that would nc in immune precipitation experiments. Thus altered products are expected in virus produc cells expressing both precursor forms relal expressing only Pr1. In virus produced by canine culture, however, where Pr2 terminates upstream of the gp32-p20 cleavage site, a shor TM protein (C in Fig. 10 ) is expected. In digestion of gp32 revealed a 22-kDa protein lanes 3 and 8) in addition to the normal 23-kE protein (Fig. 4A) (24, 26) . This is consistent with the observation that tened formof the primary targets in vivo are cells of the monocytefact, endo F macrophage lineage (24, 30, 31, 35) . The commonly used (C in Fig. 4 Malmquist variant of the virulent Wyoming strain was es-)a mature TM tablished only after extended passaging in macrophages ng C-terminal followed by successful infection of equine dermal or kidney truncated TM cells (27, 29 (17) . C-terminal processing of other lentivirus TM proteins has not been reported, but there are precedents among the much shorter TM proteins in the murine family of the type C retroviruses (13, 39) . As with EIAV, the role of this cleavage in the viral life cycle is unknown and awaits mutagenesis experiments with infectious molecular clones. Our second finding is that some cells fail to express p20 at all. In two different cell lines expressing attenuated virus, we observed truncated forms of the envelope precursor polyprotein. The point of truncation differed in the two instances, but both occurred just slightly downstream of the putative membrane-spanning region of the TM protein. In the case of the equine fetal kidney cell line, the genome expressing the truncated form was not infectious for equine dermal cells. The reason for the lack of infectivity is unknown but may be unrelated to a shortened envelope protein (for example, truncation might have resulted from an insertion or deletion, in which case the presumptive rev gene product would also be altered). In the canine thymus cell line, however, virus expressing the truncated form appeared to be much more infectious for canine cells than was virus expressing the full-size precursor. Infection of new cells, whether by exposure to virus-containing culture media or by electroporation of DNA, resulted in progressive enrichment of the short form.
In the absence of an infectious molecular clone of EIAV, we are unable to test whether the truncated envelope protein and increased infectivity are causally related. However, these results are very reminiscent of those seen with the simian immunodeficiency virus (SIV). When propagated in either cultured macaque lymphocytes or a rhesus monkey, the TM protein of SIVmac has been found to be the fulllength 41-kDa form (19, 25, 32) . When propagated in human cells, however, rapid selection for a truncated form occurred (4, 5, 19, 25, 32, 42) . Truncation resulted from the appearance of an in-frame termination codon immediately downstream of the membrane-spanning region (4, 5, 9, 16, 19, 20, 32) . When virus expressing both the full-size and the truncated envelope was introduced into macaque lymphocytes or into a monkey, rapid selection for the full-size form occurred (19, 25) . Thus, depending on the host cell, the SIV (and presumably EIAV) C-terminal extension of the TM protein plays different roles. In some cells, it is not required and even inhibits virus spread; but in cells of the animal in which the virus causes disease, it is advantageous. Termination codons in the TM-protein-coding sequence have also been found in some but not all isolates of HIV-2 (14, 28, 44) and SIVagm (1, 10, 43) .
The role of this region of the lentivirus in TM protein is unknown. Indeed, we do not even know whether it plays a role inside the infected cell during glycoprotein processing and transport or during virus assembly, at the outside of an uninfected cell during virus entry, or both. One approach to this problem is to determine the location of p20 relative to the viral membrane. There is a potential glycosylation site midway through p20 that remains unmodified (endo F had no effect on the size of the p20 fragment). This suggests that at least the midregion of the molecule was confined to the cytoplasmic side of the endoplasmic reticulum and hence is inside the virus. Similarly, immune horse antisera do not recognize p20-derived peptides (R. Montelaro, personal communication), perhaps suggesting that p20 does not appear on the cell or viral surface. However, recent studies of HIV-1 have suggested that its C-terminal region is at least membrane associated (15) and possibly membrane spanning (40) . Thus, at least part of the region may be on the outside of the virus (20, 40) . R. Montelaro (personal communication) has pointed out that the EIAV C-terminal region contains structural features (such as an amphipathic helix) that resemble those of HIV-1 (15, 40) , suggesting that the orientation of the EIAV TM protein is similar to that of HIV-1. Use of the TM peptide antisera described in this report may help us determine the locations of the various regions of the EIAV protein.
